Schizophrenia is a major type of psychotic disorders which affects around 24 million people worldwide. About seven per thousand of the adult population suffer from this chronic mental illness. While schizophrenia is treatable especially in its initial stages, around 90% of patients in developing countries are left untreated. It in turn contributes to the chronicity. Although pharmacological treatment is predominately adopted for schizophrenia, some limitations do exist. Many patients have relapsing and remitting episodes even with medication. Presence of disgusting side-effects is a main factor leading to poor drug compliance.
Journal of Steroids & Hormonal Science publish the articles in the topics of Schizophrenia. The journal is having highly qualified professors and associate professors in hormones or steroid hormones as editoial board members and review board members. The papers published by the journal are online and these papers are peer reviewed by the expert editorial board and review board. Hence, the quality of the papers being published is being maintained.
Last date updated on March, 2021